Knight v. Baxter Healthcare Corporation

CourtDistrict Court, W.D. Arkansas
DecidedMarch 25, 2021
Docket3:21-cv-03003
StatusUnknown

This text of Knight v. Baxter Healthcare Corporation (Knight v. Baxter Healthcare Corporation) is published on Counsel Stack Legal Research, covering District Court, W.D. Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Knight v. Baxter Healthcare Corporation, (W.D. Ark. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF ARKANSAS HARRISON DIVISION TAMARA KNIGHT and GARY BECK PLAINTIFFS

V. CASE NO. 3:21-CV-3003

BAXTER HEALTHCARE CORPORATION DEFENDANT

MEMORANDUM OPINON AND ORDER

Before the Court are a Motion to Dismiss and a Memorandum of Law in Support (Docs. 16 & 17) filed by Defendant Baxter Healthcare Corporation (“Baxter”). Plaintiffs Tamara Knight and Gary Beck filed a Response in Opposition (Doc. 24) and Baxter filed a Reply (Doc. 28). Baxter subsequently filed a Notice of Supplemental Authority (Doc. 45). The Motion is ripe for consideration, and for the reasons below, it is GRANTED IN PART AND DENIED IN PART. I. BACKGROUND Plaintiffs are both residents of Mountain Home, Arkansas. On March 6, 2020, Plaintiffs filed nearly identical Complaints in the Northern District of Illinois. The Complaints, which were prepared by the same attorney, both allege that emissions from Baxter’s Mountain Home industrial sterilization facility caused Plaintiffs to develop cancer. Specifically, each Complaint alleges four counts against Baxter: negligence, willful and wanton conduct, nuisance, and ultrahazardous activity. See Docs. 1 & 46. The parties then filed a joint motion to consolidate both Plaintiffs’ cases and to assign them to the same judge, which was granted. On Baxter’s motion, the case was later transferred to this Court pursuant to 28 U.S.C. § 1404(a). Baxter’s Motion to Dismiss, first filed before the District Court in Illinois, remains pending. According to the Complaints, Baxter operates an industrial sterilization facility in Mountain Home that uses the chemical ethylene oxide (“EtO”) to sterilize medical

equipment. EtO is an odorless, colorless gas and a known carcinogen. Ms. Knight has lived in Mountain Home since 1977. During that time, she has resided as close as less than half a mile and no more than four miles from the Baxter facility. Mr. Beck has lived less than a mile from the facility since 1988. Plaintiffs allege that they have been consistently and unknowingly inhaling EtO for decades and that they developed cancer as a result of this exposure. Ms. Knight was diagnosed with breast cancer in 2008, and Mr. Beck was diagnosed with myeloma in 2019. In support of their claims for relief, Plaintiffs cite the 2014 National Air Toxics Assessment (“NATA report”), released by the Environmental Protection Agency in August 2018. The NATA report is a screening tool that estimates cancer risk for tens of

thousands of census tracts across the country based on emissions data. Plaintiffs assert that the NATA report estimates the lifetime cancer risk around the Baxter facility to be three times higher than national average based on the facility’s 2014 emissions data. Plaintiffs also provide historical emissions data showing that Baxter’s emissions in 2014 were significantly lower than they were between 1987 and 2005 and between 2015 and 2018. Plaintiffs further emphasize that these self-reported data are only an estimate, and a significant portion of Baxter’s emissions are “fugitive emissions from leaking valves and other equipment,” which are “elusive in nature” and difficult to measure accurately. (Doc. 1, ¶ 35). Finally, Plaintiffs allege that Baxter has recently had to suspend operations at the Mountain Home facility because of permit violations. II. CHOICE OF LAW The Court must first determine whether Arkansas or Illinois law controls. Baxter

argues that because of the conflicts between Arkansas law and Illinois law on the issues of causation in toxic tort claims and ultrahazardous activity, further analysis under Illinois choice-of-law rules is necessary, and the application of those rules indicates that Arkansas law controls. Plaintiffs argue that Illinois law controls because further choice- of-law analysis is only required when a difference in law will make a difference in the outcome, and Illinois and Arkansas law are substantially similar on the issues in this case. A. Legal Standard When a case is transferred from another district pursuant to 28 U.S.C. § 1404(a), the Court is required to apply the choice-of-law principles of that district’s forum state. Ferens v. John Deere Co., 494 U.S. 516, 519 (1990). This case was transferred from the

Northern District of Illinois, so the Court applies Illinois choice-of-law rules. In Illinois, “[a] choice-of-law determination is required only when a difference in law will make a difference in the outcome.” Townsend v. Sears, Roebuck & Co., 879 N.E.2d 893, 898 (Ill. 2007). Additionally, Illinois courts conduct this analysis for each claim individually. See id. at 898–99. Once a conflict has been established, Illinois courts look to the Restatement (Second) of Conflict of Laws for further analysis. In a personal injury action, the law of the state where the injury occurred controls unless another state has a more significant relationship with the occurrence and with the parties. See id. at 903. Whether another state has a more significant relationship is assessed by considering two tests articulated in the Restatement of Conflicts: the “factual contacts” test found in § 145 and the policy considerations laid out in § 6. See id. The factual contacts test weighs four factors to determine the state with the most contacts to a

particular claim: “(a) the place where the injury occurred; (b) the place where the conduct causing the injury occurred; (c) the domicile, residence, nationality, place of incorporation and place of business of the parties; and (d) the place where the relationship, if any, between the parties is centered.” Id. at 901 (quoting Restatement of Conflicts § 145). Then § 6 enumerates seven different general principles to consider when weighing conflicting state laws against each other, only three of which are relevant in personal injury cases: “(b) the relevant policies of the forum; (c) the relevant policies of other interested states and the relative interests of those states in the determination of the particular issue; and (e) the basic policies underlying the particular field of law.” Id. at 907 (quoting Restatement of Conflicts § 6(b), (c), & (e)). These general principles are to be

considered in light of the § 145 analysis. Id. B. Discussion In accordance with Illinois choice-of-law rules, the Court will first address whether Baxter has met its burden to establish a conflict between Arkansas and Illinois law with respect to causation in toxic tort cases and ultrahazardous activity claims. Arkansas applies the test articulated by Chavers v. General Motors Corp. to determine causation in toxic tort cases. 79 S.W.3d 361 (Ark. 2002). Under the Chavers test, also known as the “frequency, regularity, and proximity” test, a plaintiff is required to prove: (1) exposure to a toxic substance that was spread by the defendant; (2) with sufficient frequency and regularity, (3) in proximity to where the plaintiff lived, (4) such that it is probable that the exposure to such toxic substance caused the plaintiff’s injuries. Id. at 369. While plaintiffs need not prove a “mathematically precise table equating levels of exposure with levels of harm,” Wright v. Willamette Indus., Inc., 91 F.3d 1105, 1107

(8th Cir. 1996) (applying Arkansas law), a “threshold showing that [they were] exposed to toxic levels known to cause the type of injuries” they suffered is required. Bell v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ferens v. John Deere Co.
494 U.S. 516 (Supreme Court, 1990)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Wright v. Willamette Industries, Inc.
91 F.3d 1105 (Eighth Circuit, 1996)
Braden v. Wal-Mart Stores, Inc.
588 F.3d 585 (Eighth Circuit, 2009)
Wagner v. General Motors Corp.
258 S.W.3d 749 (Supreme Court of Arkansas, 2007)
State v. Diamond Lakes Oil Co.
66 S.W.3d 613 (Supreme Court of Arkansas, 2002)
Little Rock Land Company v. Raper
433 S.W.2d 836 (Supreme Court of Arkansas, 1968)
Ozark Bi-Products, Inc. v. Bohannon
271 S.W.2d 354 (Supreme Court of Arkansas, 1954)
Mangrum v. Pigue
198 S.W.3d 496 (Supreme Court of Arkansas, 2004)
Ozark Poultry Products, Inc. v. Garman
472 S.W.2d 714 (Supreme Court of Arkansas, 1971)
Southeast Arkansas Landfill, Inc. v. State
858 S.W.2d 665 (Supreme Court of Arkansas, 1993)
Chavers v. General Motors Corp.
79 S.W.3d 361 (Supreme Court of Arkansas, 2002)
Green v. Alpharma, Inc.
284 S.W.3d 29 (Supreme Court of Arkansas, 2008)
Martin v. Arthur
3 S.W.3d 684 (Supreme Court of Arkansas, 1999)
Shepherd v. Washington County
962 S.W.2d 779 (Supreme Court of Arkansas, 1998)
Aviation Cadet Museum, Inc. v. Hammer
283 S.W.3d 198 (Supreme Court of Arkansas, 2008)
Castello v. Kalis
816 N.E.2d 782 (Appellate Court of Illinois, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Knight v. Baxter Healthcare Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/knight-v-baxter-healthcare-corporation-arwd-2021.